Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000356779 | SCV000395648 | uncertain significance | Tuberous sclerosis syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697713 | SCV000535087 | likely benign | not provided | 2021-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000462476 | SCV000556563 | likely benign | Tuberous sclerosis 2 | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022072 | SCV001183764 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000462476 | SCV002039836 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000356779 | SCV004824245 | likely benign | Tuberous sclerosis syndrome | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004544573 | SCV004784223 | likely benign | TSC2-related disorder | 2023-04-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |